ProMIS Neurosciences Inc (PMN)

NASDAQ
Currency in USD
0.640
-0.022(-3.32%)
Closed
PMN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected today
Fair Value
Day's Range
0.6400.660
52 wk Range
0.6212.610
Key Statistics
Edit
Prev. Close
0.64
Open
0.66
Day's Range
0.64-0.66
52 wk Range
0.621-2.61
Volume
10.56K
Average Volume (3m)
44.56K
1-Year Change
-67.68%
Book Value / Share
0.24
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PMN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
7.713
Upside
+1,105.15%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

ProMIS Neurosciences Inc Company Profile

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company’s proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Compare PMN to Peers and Sector

Metrics to compare
PMN
Peers
Sector
Relationship
P/E Ratio
−37.1x−2.4x−0.5x
PEG Ratio
−0.38−0.060.00
Price/Book
2.9x0.0x2.6x
Price / LTM Sales
-0.9x3.0x
Upside (Analyst Target)
-398.2%55.3%
Fair Value Upside
Unlock−3.1%9.8%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.713
(+1,105.15% Upside)

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
0.31 / -0.07
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

0.503
GBIO
-2.52%
0.280
SCLX
0.00%
0.268
XAIR
+1.52%
0.555
IPSC
+0.91%

FAQ

What Is the ProMIS Neurosciences (PMN) Stock Price Today?

The ProMIS Neurosciences stock price today is 0.64

What Stock Exchange Does ProMIS Neurosciences Trade On?

ProMIS Neurosciences is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for ProMIS Neurosciences?

The stock symbol for ProMIS Neurosciences is "PMN."

What Is the ProMIS Neurosciences Market Cap?

As of today, ProMIS Neurosciences market cap is 20.92M.

What is ProMIS Neurosciences Earnings Per Share?

The ProMIS Neurosciences EPS is -0.025.

What Is the Next ProMIS Neurosciences Earnings Date?

ProMIS Neurosciences will release its next earnings report on 23 Mar 2025.

From a Technical Analysis Perspective, Is PMN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.